Ticker

Rocket Doctor Inc. has been selected as one of Canada's Top 100 AI and Tech Startups, recognizing the Company's leadership in applying artificial intelligence to improve healthcare access and patient outcomes. Selected from more than 330 applicants, Rocket Doctor AI will showcase its AI-powered healthcare platform at ALL IN 2026, Canada's largest event dedicated to artificial intelligence and advanced technologies.

Rocket Doctor signs its first value-based primary care agreement, enabling physicians to manage assigned patient panels under a recurring per-member-per-month care model. Rocket Doctor will add hundreds of patients to primary care provider panels, marking an important milestone in Rocket Doctor's U.

Vancouver, BC, June 12, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) ("Rocket Doctor AI") has granted an aggregate 47,013 stock options, exercisable at $0. 71 per share and valid for a term of three years, and an aggregate 514,801 restricted share units, valid for a term between one to three years, to consultants and employees of the Company and its subsidiaries.

Vancouver, BC, May 27, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) ("Rocket Doctor AI" or the "Company"), a physician-built, AI-powered healthcare technology company focused on empowering doctors and expanding access to high-quality care, is pleased to announce that it will host a comprehensive Company Town Hall on Wednesday, June 3, 2026.

Continued organic quarter over quarter revenue growth with growth of over 30% from Q3 to Q4 2025 (from $529,123 in Q3 2025 to $697,340 for Q4 2025) Earnings per share for Q4, 2025: ($0. 10) per share. Annual Revenues of $1. 739 million in FY2025 Announced signed in-network contracts and credentialing with several major U.